Scientific and Medical Equipment House Past Earnings Performance
Past criteria checks 4/6
Scientific and Medical Equipment House's earnings have been declining at an average annual rate of -27%, while the Healthcare industry saw earnings growing at 20.3% annually. Revenues have been growing at an average rate of 8.7% per year. Scientific and Medical Equipment House's return on equity is 7.9%, and it has net margins of 4.8%.
Key information
-27.0%
Earnings growth rate
-27.2%
EPS growth rate
| Healthcare Industry Growth | 12.3% |
| Revenue growth rate | 8.7% |
| Return on equity | 7.9% |
| Net Margin | 4.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Scientific and Medical Equipment House's (TADAWUL:4014) Strong Earnings Are Of Good Quality
Nov 19
We Think That There Are Issues Underlying Scientific and Medical Equipment House's (TADAWUL:4014) Earnings
Apr 10Recent updates
Scientific and Medical Equipment House's (TADAWUL:4014) Strong Earnings Are Of Good Quality
Nov 19We Think That There Are Issues Underlying Scientific and Medical Equipment House's (TADAWUL:4014) Earnings
Apr 10Potential Upside For Scientific and Medical Equipment House Company (TADAWUL:4014) Not Without Risk
Mar 21Scientific and Medical Equipment House Company (TADAWUL:4014) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Aug 14Scientific and Medical Equipment House's (TADAWUL:4014) Shareholders May Want To Dig Deeper Than Statutory Profit
Jun 08Revenue & Expenses Breakdown
How Scientific and Medical Equipment House makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 885 | 43 | 55 | 0 |
| 30 Jun 24 | 878 | 48 | 67 | 0 |
| 31 Mar 24 | 852 | 42 | 70 | 0 |
| 31 Dec 23 | 799 | 40 | 66 | 0 |
| 30 Sep 23 | 756 | 1 | 109 | 0 |
| 30 Jun 23 | 731 | -8 | 117 | 0 |
| 31 Mar 23 | 716 | 8 | 120 | 0 |
| 31 Dec 22 | 714 | 18 | 118 | 0 |
| 30 Sep 22 | 730 | 60 | 86 | 0 |
| 30 Jun 22 | 721 | 69 | 81 | 0 |
| 31 Mar 22 | 710 | 75 | 73 | 0 |
| 31 Dec 21 | 699 | 78 | 70 | 0 |
| 30 Sep 21 | 649 | 76 | 61 | 0 |
| 30 Jun 21 | 627 | 76 | 61 | 0 |
| 31 Mar 21 | 615 | 73 | 61 | 0 |
| 31 Dec 20 | 617 | 75 | 64 | 0 |
| 31 Dec 19 | 597 | 71 | 67 | 0 |
| 31 Dec 18 | 584 | 68 | 50 | 0 |
| 31 Dec 17 | 556 | 49 | 54 | 0 |
Quality Earnings: 4014 has high quality earnings.
Growing Profit Margin: 4014's current net profit margins (4.8%) are higher than last year (0.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4014's earnings have declined by 27% per year over the past 5 years.
Accelerating Growth: 4014's earnings growth over the past year (3578.6%) exceeds its 5-year average (-27% per year).
Earnings vs Industry: 4014 earnings growth over the past year (3578.6%) exceeded the Healthcare industry 15.7%.
Return on Equity
High ROE: 4014's Return on Equity (7.9%) is considered low.